Delivery Order SPE2DB24D8002-SPE2DB25FJPKR
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $4,608.75 firm fixed-price delivery order is for the supply of Estradiol 0.01% cream, with an ultimate completion date of July 11, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V...
- This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business in Anoka, Minnesota, was issued by the Defense Logistics Agency (DLA). The $3,938.04 Firm Fixed Price delivery order is for YUVAFEM 10 MCG VAGINAL INSERT 18S medical supplies. The award is part of Dakota Drug, Inc.'s single-award Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00 and running through December 31,...
- This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a Delivery Order valued at $3,462.21 with a Firm Fixed Price pricing type. The ultimate completion date is June 24, 2025. The contract was awarded by the Defense Logistics Agency (DLA), which is a defense agency, for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S. This contract is associated with a larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,625.23 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, carries no set-aside designation and represents work performed at the contractor's Anoka location. Dakota Drug, Inc. leverages its...
- The Defense Logistics Agency Troop Support Medical awarded a $45,140 firm fixed price delivery order to Dakota Drug, Inc. for the supply of 0.05 mg estradiol patches (1 per week) in quantities of 4. This order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle to support the agency's medical supply needs. Dakota Drug will deliver the patches to a location in Minot, North Dakota by August 30, 2023 to fulfill requirements originally solicited from the prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.71 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Premarin 0.625 mg tablets (100-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,125.75 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count). The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,219.36, is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, known...
- The Defense Logistics Agency awarded a $2,122.94 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of eluryng vaginal rings. The contract, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is executed under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJPKRDelivery Order
The Defense Logistics Agency awarded a $1,947.48 firm fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Estradiol 10 MCG Vaginal Inserts (8-count packages). The contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a delivery order under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program. This IDC, valued at $999,999,999.00 and extending through December 31, 2025, authorizes the company to provide comprehensive pharmaceutical products and medical supplies to support U.S. Armed Forces medical operations. The award carries no set-aside designation and will be performed in Anoka, Minnesota. Dakota Drug, Inc. serves as a critical vendor in the federal medical supply chain, with a demonstrated track record of delivering diverse pharmaceutical and medical products to military healthcare facilities since its SAM.gov registration in 2001. The company's capabilities encompass diabetes management products, respiratory medications, pain management drugs, hormonal treatments, cardiovascular medications, and vaccines, making it well-positioned to fulfill the hormone replacement therapy product specified in this delivery order. This contract award reflects the ongoing dependency of the Defense Logistics Agency on established pharmaceutical suppliers to maintain adequate medical inventories for U.S. Armed Forces personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/27/25 |